(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-08 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1006710
| Date | Daily Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 0.91 | 0.91 | 0.94 | 0.91 | 0.369 times |
| 07 Mon Oct 2024 | 0.91 | 0.94 | 0.96 | 0.90 | 0.523 times |
| 04 Fri Oct 2024 | 0.95 | 0.90 | 0.96 | 0.89 | 0.725 times |
| 03 Thu Oct 2024 | 0.90 | 0.87 | 0.91 | 0.86 | 1.358 times |
| 02 Wed Oct 2024 | 0.87 | 0.91 | 0.92 | 0.87 | 1.88 times |
| 01 Tue Oct 2024 | 0.92 | 0.94 | 0.95 | 0.91 | 0.554 times |
| 30 Mon Sep 2024 | 0.95 | 0.98 | 1.00 | 0.93 | 0.488 times |
| 27 Fri Sep 2024 | 0.98 | 0.96 | 1.01 | 0.94 | 1.109 times |
| 26 Thu Sep 2024 | 0.94 | 0.93 | 0.95 | 0.91 | 1.001 times |
| 25 Wed Sep 2024 | 0.92 | 0.97 | 0.99 | 0.91 | 1.752 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.9 as stoploss in an intra day buy trade for a target of 0.98. However, stock will show a bearish move below 0.9.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.83 |
| Downside Target | 0.86 |
| Downside Target | 0.90 |
| Upside Target | 0.94 |
| Upside Target | 0.96 |
| Upside Target | 0.98 |
| Upside Target | 1.00 |
| Upside Target | 1.06 |
| Upside Target | 1.12 |
| Upside Target | 1.15 |
| Upside Target | 1.17 |
| Upside Target | 1.32 |
| Upside Target | 1.36 |
| Upside Target | 1.48 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 0.89 |
| Downside Intraday Target | 0.86 |
| Upside Intraday Target | 0.95 |
| Upside Intraday Target | 0.98 |
| Upside Intraday Target | 0.92 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 0.91 | 0.94 | 0.96 | 0.90 | 0.178 times |
| 04 Fri Oct 2024 | 0.95 | 0.98 | 1.00 | 0.86 | 0.748 times |
| 27 Fri Sep 2024 | 0.98 | 1.00 | 1.01 | 0.87 | 1.288 times |
| 20 Fri Sep 2024 | 1.00 | 1.12 | 1.12 | 0.98 | 1.454 times |
| 13 Fri Sep 2024 | 1.11 | 1.08 | 1.17 | 1.06 | 0.79 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 08 Tue Oct 2024 | 0.91 | 0.94 | 0.96 | 0.86 | 0.264 times |
| 30 Mon Sep 2024 | 0.95 | 1.24 | 1.32 | 0.87 | 0.403 times |
| 30 Fri Aug 2024 | 1.27 | 1.33 | 1.36 | 0.94 | 1.214 times |
| 31 Wed Jul 2024 | 1.33 | 1.00 | 1.48 | 0.98 | 1.232 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.92 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.92 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.